Search

This column is intended to address the kinds of knotty problems and dilemmas with which many scholars grapple in studying health professions education. In this article, the authors address the question of why papers may be desk rejected (rejected without going out for formal peer review) and describe simple steps for authors to optimize their work so it gets past the desk reject stage. Submitted/Accepted version

A series of new coloring materials in nanoscale based on 5-(2-aminothiazol-5-yl) thiazol-2-amine and 5-(4-aminophenyl) thiazol-2-amine were synthesized. The nanoscale pigments were prepared using a grinding high˗energy ball-milling technique. X-ray diffraction and transmission electron microscopy were employed to determine the particle size of the nanoscale pigments (40–80 nm). The synthesized pigments in normal and nanoscale were applied in the printing of polyester fabrics. The fastness and colorimetric properties of the printed samples were carefully studied. Additionally, the synthesized pigments were applied as water-based flexographic ink for paper and carton. The hue of the color pigments L*, a*, b*, glossiness, and fastness to light were measured. The comparison of the new heterocyclic benzidine analogs in normal and nanoscale with commercial benzidine pigments demonstrated better results, particularly for the nanoscale pigments.

SummaryInhibitors of the cyclin-dependent kinases 4/6 (CDK4/6i) have been practice-changing and are now considered the standard of care in combination with endocrine therapy for the first- or second-line treatment in advanced hormone-receptor-positive, human epidermal growth factor receptor 2‑negative breast cancer. Recently, CDK4/6i have also emerged as an appealing targeted cancer therapy in early breast cancer, however results of large clinical trials are controversial. This position paper summarizes the evidence, and provides guidance for clinical practice.

Magnetic Resonance Imaging linear-accelerator (MRI-linac) equipment has recently been introduced to multiple centres in Australia and New Zealand. MRI equipment creates hazards for staff, patients and others in the MR environment; these hazards must be well understood, and risks managed by a system of environmental controls, written procedures and a trained workforce. While MRI-linac hazards are similar to the diagnostic paradigm, the equipment, workforce and environment are sufficiently different that additional safety guidance is warranted. In 2019 the Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM) formed the Magnetic Resonance Imaging Linear-Accelerator Working Group (MRILWG) to support the safe clinical introduction and optimal use of MR-guided radiation therapy treatment units. This Position Paper is intended to provide safety guidance and education for Medical Physicists and others planning for and working with MRI-linac technology. This document summarises MRI-linac hazards and describes particular effects which arise from the combination of strong magnetic fields with an external radiation treatment beam. This document also provides guidance on safety governance and training, and recommends a system of hazard management tailored to the MRI-linac environment, ancillary equipment, and workforce.